Who is sponsoring NCT03032315?

NCT03032315 is sponsored by IlDong Pharmaceutical Co Ltd.

What drugs are being tested in NCT03032315?

Interventions in NCT03032315: TAH Tablet (Telmisartan80/Amlodipine besylate10/Hydrochlorothiazide12.5), TWYNSTA(Telmisartan+Amlodipine besylate), Hydrochlorothiazide.

Is NCT03032315 still recruiting?

NCT03032315 is currently completed. Last updated 26 January 2017.

Last reviewed 2017-01-26 · How we verify

NCT03032315

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Compare the Pharmacokinetics of TAH(80/10/12.5) Tablet in Comparison to the Co-administration of Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male Volunteers

Completed Phase 1 Last updated 26 January 2017

What this trial tests

Phase 1 trial testing TAH Tablet (Telmisartan80/Amlodipine besylate10/Hydrochlorothiazide12.5) in Healthy in 44 participants. Completed in 27 December 2016.

Timeline

1 October 2016

Primary endpoint
27 December 2016

27 December 2016

Quick facts

Lead sponsor	IlDong Pharmaceutical Co Ltd
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	treatment
Enrollment	44
Start date	1 October 2016
Primary completion	27 December 2016
Estimated completion	27 December 2016
Sites	1 location across South Korea

Drugs / interventions tested

TAH Tablet (Telmisartan80/Amlodipine besylate10/Hydrochlorothiazide12.5) — full drug profile →
TWYNSTA(Telmisartan+Amlodipine besylate) — full drug profile →
Hydrochlorothiazide (hydrochlorothiazide) — full drug profile →

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

IlDong Pharmaceutical Co Ltd — full company profile →

Who can join

Adults 19 to 55, male only, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

randomized, open-label, single dose, replicate crossover clinical trial to compare the pharmacokinetics of TAH(80/10/12.5) tablet in comparison to the co-administration of telmisartan, amlodipine and hydrochlorothiazide in healthy male volunteers

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other IlDong Pharmaceutical Co Ltd trials

Trials by the same sponsor.

NCT06635226 — Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ID110521156 in Healthy Adult Subjects · Phase 1 · recruiting
NCT06063291 — Single Ascending Oral Dose Phase 1 Study of ID110521156 in Healthy Adult Subjects · Phase 1 · completed
NCT05663879 — Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of ID120040002 in Healthy Volunteers · Phase 1 · unknown
NCT05604287 — Safety, Tolerability, and Pharmacokinetics of ID119031166M With the Exploration of Pharmacodynamic Effects · Phase 1 · terminated
NCT05259020 — To Evaluate the Pharmacokinetics and the Safety of ID14009 Compared to Coadministration of ID1805 With ID1803 in Healthy · Phase 1 · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03032315 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by IlDong Pharmaceutical Co Ltd
Last refreshed: 26 January 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03032315.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing